Frovatriptan succinate hydrate, CAS [[158930-17-7]]

Produktübersicht

• Artikelname: Frovatriptan succinate hydrate, CAS [[158930-17-7]]
• Artikelnummer: TGM-T11326
• Hersteller Artikelnummer: T11326
• Alternativnummer: TGM-T11326-1MLX10MM(INDMSO), TGM-T11326-2MG, TGM-T11326-5MG, TGM-T11326-10MG, TGM-T11326-25MG, TGM-T11326-50MG, TGM-T11326-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: Frovelan , Frova

Produktbeschreibung

Frovatriptan succinate hydrate (Frova) is effective in treating the full spectrum of migraine including the associated symptoms of nausea, vomiting, photophobia, and phonophobia. Frovatriptan succinate hydrate can also be used as in mini-prophylaxis in menstrual migraine. Frovatriptan succinate hydrate is a potent, high affinity, selective and orally active 5-HT1B, HT1D receptor agonist and a moderately potent 5-HT7 receptor agonist, with pKi values of 8.6, 8.4, and 6.7, respectively.

Produkteigenschaften

• Molekulargewicht: 379.41
• Reinheit: 99.66%
• CAS Nummer: [158930-17-7]
• Formel: C18H25N3O6
• Target-Kategorie: 5-HT Receptor

Bilder

T11326